Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-01

Clinical Trial Update: Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating remifentanil for sedation in patients with traumatic brain injury (TBI). The snippet does …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)

Snippet

Sponsor: Joseph D. Tobias | Conditions: Traumatic Brain Injury | Status: COMPLETED